Published Date: 26 Apr 2023
According to researchers from the Karolinska Institutet, patients with Crohn's disease and IBD have an elevated risk of developing lymphoma, and this risk has grown over the past few years.
Read Full News1.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
2.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
3.
Taking Charge of Your Cancer Journey.
4.
Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends
5.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
1.
Clinical Guidelines for Monitoring Minimal Residual Disease Biology in Solid Tumors
2.
Bone Marrow Functional Reserve Screening in Healthy Aging
3.
Quality of Life Following Restoration of Functional Hematopoietic Resilience
4.
Rehabilitation Following Hematopoietic Functional Reconstitution: Evidence-Based Clinical Review
5.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation